These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 14705122)
1. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Tong J; Fitzmaurice PS; Ang LC; Furukawa Y; Guttman M; Kish SJ Ann Neurol; 2004 Jan; 55(1):125-9. PubMed ID: 14705122 [TBL] [Abstract][Full Text] [Related]
2. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related]
3. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ashour R; Jankovic J Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460 [TBL] [Abstract][Full Text] [Related]
4. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Bukhatwa S; Zeng BY; Rose S; Jenner P Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003 [TBL] [Abstract][Full Text] [Related]
6. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720 [TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875 [TBL] [Abstract][Full Text] [Related]
8. Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease. Rascol O; Sabatini U; Fabre N; Senard JM; Simonetta-Moreau M; Montastruc JL; Clanet M; Rascol A Mov Disord; 1995 Mar; 10(2):163-70. PubMed ID: 7753058 [TBL] [Abstract][Full Text] [Related]
9. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242 [TBL] [Abstract][Full Text] [Related]
10. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116 [TBL] [Abstract][Full Text] [Related]
11. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy. Holmberg B; Johnels B; Blennow K; Rosengren L Mov Disord; 2003 Feb; 18(2):186-90. PubMed ID: 12539213 [TBL] [Abstract][Full Text] [Related]
13. New and reliable MRI diagnosis for progressive supranuclear palsy. Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570 [TBL] [Abstract][Full Text] [Related]